BAVINA SOOKDEO Every year, millions around the world lose their sight – not because their condition was untreatable, but because it was detected...
Vous n'êtes pas connecté
Maroc - DESANG.NET - A la Une - 13/Jan 08:42
Trial data has shown that the old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential of reducing the need for retinal laser or intravitreal injection treatment. In the LENS trial of more than 1100 people randomly assigned to fenofibrate or […]
BAVINA SOOKDEO Every year, millions around the world lose their sight – not because their condition was untreatable, but because it was detected...
BAVINA SOOKDEO Every year, millions around the world lose their sight – not because their condition was untreatable, but because it was detected...
A new trial will evaluate whether integrating autonomous AI screening for diabetic retinopathy into U.S. federally qualified health centers can boost...
MELBOURNE, Oct. 28 (Xinhua) -- An international study involving Australian scientists has identified a potential new drug that may protect against...
MELBOURNE, Oct. 28 (Xinhua) -- An international study involving Australian scientists has identified a potential new drug that may protect against...
While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more...
This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of...
Rosuvastatin and atorvastatin are two of the most common medications used to lower LDL cholesterol, often called “bad” cholesterol. Doctors...
Rosuvastatin and atorvastatin are two of the most common medications used to lower LDL cholesterol, often called “bad” cholesterol. Doctors...
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease.